Use within 8 weeks for optimal potency
While still speculative, its incorporation into topical formulations might offer unique avenues for aiding post-procedure dermal layer recovery or addressing chronic dermatological conditions like eczema and psoriasis
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
For HCC-1806, MDAMB231, and MDAMB468, n of technical replicates are: Control = 12
v Martin E, Coert JH, Flucke UE, Slooff WM, van de Sande MAJ, van Noesel MM, et al